Companies › Eli Lilly › Operating cash flow
Eli Lilly operating cash flow, 2008–2025
Eli Lilly reported operating cash flow of $16.8 billion for the fiscal year ended Dec. 31, 2025, up 90.7% from $8.82 billion the year before, according to its Form 10-K.
Fiscal years labeled by the year in which they ended. Bars drawn from the table below.
Eli Lilly operating cash flow by fiscal year
| Fiscal year ended | Operating cash flow | Change | Filing |
|---|---|---|---|
| Dec. 31, 2025 | $16.8B | +90.7% | 10-K (2026) ↗ |
| Dec. 31, 2024 | $8.82B | +108.0% | 10-K (2026) ↗ |
| Dec. 31, 2023 | $4.24B | −44.1% | 10-K (2026) ↗ |
| Dec. 31, 2022 | $7.59B | +3.0% | 10-K (2025) ↗ |
| Dec. 31, 2021 | $7.37B | +13.3% | 10-K (2024) ↗ |
| Dec. 31, 2020 | $6.50B | +34.4% | 10-K (2023) ↗ |
| Dec. 31, 2019 | $4.84B | −12.5% | 10-K (2022) ↗ |
| Dec. 31, 2018 | $5.52B | −1.6% | 10-K (2021) ↗ |
| Dec. 31, 2017 | $5.62B | +15.8% | 10-K (2020) ↗ |
| Dec. 31, 2016 | $4.85B | +63.6% | 10-K (2019) ↗ |
| Dec. 31, 2015 | $2.96B | −33.5% | 10-K (2018) ↗ |
| Dec. 31, 2014 | $4.46B | −22.3% | 10-K (2017) ↗ |
| Dec. 31, 2013 | $5.74B | +8.1% | 10-K (2016) ↗ |
| Dec. 31, 2012 | $5.30B | −26.7% | 10-K (2015) ↗ |
| Dec. 31, 2011 | $7.23B | +5.5% | 10-K (2014) ↗ |
| Dec. 31, 2010 | $6.86B | +58.2% | 10-K (2013) ↗ |
| Dec. 31, 2009 | $4.34B | −40.6% | 10-K (2012) ↗ |
| Dec. 31, 2008 | $7.30B | — | 10-K (2011) ↗ |
Other Eli Lilly financials
RevenueNet incomeDiluted EPSR&D expenseDividends per shareDiluted sharesTotal assetsCash and equivalentsStockholders' equity Quarterly results and next earnings date Eli Lilly company hub
FAQ
Q What was Eli Lilly's operating cash flow in its latest fiscal year?
A Eli Lilly reported operating cash flow of $16.8 billion for the fiscal year ended Dec. 31, 2025, up 90.7% from $8.82 billion the year before, according to its Form 10-K.
Q What is Eli Lilly's highest annual operating cash flow on record here?
A $16.8 billion, in the fiscal year ended Dec. 31, 2025, among the fiscal years 2008–2025 reported in its 10-K XBRL data.
Q Where does this operating cash flow data come from?
A From Eli Lilly's annual reports on Form 10-K, as tagged in XBRL and published by the SEC (company facts). Net cash provided by (used in) operating activities, from the cash flow statement.
Source: Eli Lilly's annual reports on Form 10-K via SEC XBRL company facts, updated Oct. 15, 2026. Net cash provided by (used in) operating activities, from the cash flow statement. For each year the most recent 10-K that reports it is used, so a figure a company later restated shows the restated value; the filing link shows which report it came from. Change is our arithmetic. Financial data, not investment advice.